Toxoplasma gondii encephalitis

Also known as: Encephalitis toxoplasmal / Acquired toxoplasmal meningoencephalitis / Meningoencephalitis due to toxoplasmosis / Cerebral toxoplasmosis / Toxoplasmal encephalitis / Toxoplasma meningoencephalitis / Toxoplasmosis, Cerebral

DrugDrug NameDrug Description
DB01117AtovaquoneA hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols. [PubChem]
DB01190ClindamycinClindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. It may be bacteriostatic or bactericidal depending on the organism and drug concentration.
DB01015SulfamethoxazoleA bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
DrugDrug NamePhaseStatusCount